Medication info
Olmesartan Medoxomil/Amlodipine Besilate/Hydrochlorothiazide Tablets 5/20/12.5 mg

Olmesartan Medoxomil/Amlodipine Besilate/Hydrochlorothiazide Tablets 5/20/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Kyeongdong Pharmaceutical Co., Ltd.
Appearance
White and orange round film-coated tablets
Packaging
30 tablets (10 tablets/Alu-Alu × 3)
Approval status
Active

MFDS item code 201805341 · Approved 2018.12.28 · Insurance code 648104210

Summary

Main use
Treatment of essential hypertension not controlled with combination therapy
Who takes it
Adults · Children
Adult dose
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual ingredients (amlodipine and olmesartan medoxomil as monotherapy or combination therapy). However, if blood pressure is not controlled with combination therapy of amlodipine and olmesartan medoxomil as described below, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40/25mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide. The maximum blood pressure-lowering effect occurs within 2 weeks of administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/20mg. - 5/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/40mg or with this medicine 5/20/12.5mg. - 5/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/12.5mg. - 10/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 10/40mg or with this medicine 5/40/12.5mg. - 10/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/25mg or this medicine 10/40/12.5mg. ※ Refer to the following dose-escalation schedule. (The content of each ingredient is listed in the order of amlodipine/olmesartan medoxomil/hydrochlorothiazide.) 5/20/0mg → 5/20/12.5mg ↓ 5/40/0mg → 5/40/12.5mg → 5/40/25mg ↓ ↓ 10/40/0mg → 10/40/12.5mg → 10/40/25mg ၀ Patients with renal impairment The maximum dose of this medicine for patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min) is 20/5/12.5 milligrams once daily. For patients with moderate renal impairment, monitoring of potassium and creatinine levels is recommended. This medicine should not be administered to patients with severe renal impairment (creatinine clearance < 30mL/min). ၀ Patients with hepatic impairment Use with caution in patients with mild to moderate hepatic impairment. The maximum dose of this medicine for patients with moderate hepatic impairment is 5/20/12.5 milligrams once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment. This medicine should not be administered to patients with severe hepatic impairment. ၀ Elderly patients (65 years and older) In general, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in elderly patients. Since there is very limited experience with the use of this medicine in elderly patients aged 75 years and older, monitor them very carefully when administering this medicine.
Child dose
Under 18 years of age: Use of this medicine is not recommended.

Ingredients

Manufacturer
Kyeongdong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with combination therapy

  • Essential hypertension
View approved original text

This medication is used when blood pressure control is difficult in patients with essential hypertension when taken in combination with amlodipine and olmesartan medoxomil. These two medications work to dilate blood vessels and reduce blood pressure, effectively aiding in blood pressure control. It is particularly suitable for patients for whom blood pressure control is difficult with a single drug alone. By stabilizing blood pressure, it helps reduce the risk of cardiovascular diseases. Hence, it is effectively used in the treatment of essential hypertension.

How to take

Adult dose

Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual ingredients (amlodipine and olmesartan medoxomil as monotherapy or combination therapy). However, if blood pressure is not controlled with combination therapy of amlodipine and olmesartan medoxomil as described below, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40/25mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide. The maximum blood pressure-lowering effect occurs within 2 weeks of administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/20mg. - 5/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/40mg or with this medicine 5/20/12.5mg. - 5/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/12.5mg. - 10/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 10/40mg or with this medicine 5/40/12.5mg. - 10/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/25mg or this medicine 10/40/12.5mg. ※ Refer to the following dose-escalation schedule. (The content of each ingredient is listed in the order of amlodipine/olmesartan medoxomil/hydrochlorothiazide.) 5/20/0mg → 5/20/12.5mg ↓ 5/40/0mg → 5/40/12.5mg → 5/40/25mg ↓ ↓ 10/40/0mg → 10/40/12.5mg → 10/40/25mg ၀ Patients with renal impairment The maximum dose of this medicine for patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min) is 20/5/12.5 milligrams once daily. For patients with moderate renal impairment, monitoring of potassium and creatinine levels is recommended. This medicine should not be administered to patients with severe renal impairment (creatinine clearance < 30mL/min). ၀ Patients with hepatic impairment Use with caution in patients with mild to moderate hepatic impairment. The maximum dose of this medicine for patients with moderate hepatic impairment is 5/20/12.5 milligrams once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment. This medicine should not be administered to patients with severe hepatic impairment. ၀ Elderly patients (65 years and older) In general, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in elderly patients. Since there is very limited experience with the use of this medicine in elderly patients aged 75 years and older, monitor them very carefully when administering this medicine.

Child dose

Under 18 years of age: Use of this medicine is not recommended.

Precautions

This medication may cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients in this medication or similar drugs, pregnant or breastfeeding individuals, and those with severe hypotension or problems with heart and kidney function should not take this medication. Patients with low blood volume or compromised kidney function may experience side effects like hypotension, so it is essential to check their condition adequately before taking this medication. Patients with poor liver function, certain heart conditions, or electrolyte imbalances should take this medication with caution and have regular examinations as directed by their physician. Since this medication can lower blood pressure, it may cause dizziness or drowsiness, so caution is advised when driving or operating dangerous machinery. During the use of this medication, the skin may become sensitive to sunlight, so avoiding sun exposure or using sunscreen is recommended. Breastfeeding individuals are advised to avoid taking this medication or discontinue breastfeeding. It is not advisable to administer this medication to children under 18, as its safety has not been established. Elderly individuals may experience stronger effects or side effects due to reduced kidney and liver function, so starting at a lower dose and taking it cautiously is recommended. In case of overdose, severe hypotension or heart function abnormalities may occur, so the dosage must be strictly adhered to, and immediate medical attention should be sought if abnormal symptoms appear. This medication may interact with lithium, certain anti-inflammatory pain relievers, and other blood pressure medications, so it is essential to consult with a doctor or pharmacist if other medications are being taken. Regular blood tests and kidney function tests are necessary, and if symptoms of electrolyte imbalance (muscle cramps, weakness, palpitations, etc.) occur, they should be reported immediately. If skin or eye abnormalities occur while taking this medication, healthcare professionals should be informed immediately.

Side effects

Peripheral edema, headache, dizziness, upper respiratory tract infection, nasopharyngitis, urinary tract infection, sialadenitis, leukopenia, thrombocytopenia, bone marrow suppression, neutropenia, agranulocytosis, hemolytic anemia, aplastic anemia, anaphylactic reaction, drug hypersensitivity, hyperkalemia, hypokalemia, loss of appetite, diabetes, hypercalcemia, hyperglycemia, hypomagnesemia, hyponatremia, hypochloremia, hypertriglyceridemia, hypercholesterolemia, hyperuricemia, hypochloremic alkalosis, hyperamylasemia, confusional state, depression, apathy, sensitivity to stimuli, anxiety, mood changes, sleep disturbances, dizziness, orthostatic dizziness, syncope, taste disturbance, hypertonia, sensory impairment, paresthesia, peripheral neuropathy, drowsiness, syncope, seizures, loss of appetite, tremors, visual disturbances, decreased tears, worsening myopia, jaundice, vertigo, tinnitus, palpitations, tachycardia, myocardial infarction, arrhythmia, angina, hypotension, flushing, orthostatic hypotension, vasculitis, thrombosis, embolism, cough, bronchitis, shortness of breath, pharyngitis, rhinitis, acute interstitial pneumonia, respiratory distress syndrome, pulmonary edema, diarrhea, nausea, constipation, dry mouth, abdominal pain, changes in bowel habits, abdominal distension, dyspepsia, gastritis, gastric discomfort, gastroenteritis, gingival hyperplasia, paralytic obstruction, pancreatitis, vomiting, hepatitis, jaundice, acute cholecystitis, autoimmune hepatitis, hair loss, angioedema, allergic dermatitis, erythema multiforme, erythema, lupus erythematosus-like skin reaction, exanthematous pustulosis, exfoliative dermatitis, hyperhidrosis, photosensitivity reaction, pruritus, purpura, Quincke's edema, rash, recurrence of lupus erythematosus, toxic skin necrosis, Stevens-Johnson syndrome, urticaria, muscle spasms, joint edema, muscle weakness, ankle edema, arthralgia, arthritis, low back pain, partial paralysis, myalgia, bone pain, frequency of urination, acute renal failure, hematuria, urination disorders, nocturia, interstitial nephritis, renal failure, erectile dysfunction, gynecomastia, asthenia, fatigue, chest pain, fever, influenza-like symptoms, lethargy, malaise, edema, pain, facial swelling, elevated serum creatinine, elevated blood urea, elevated serum uric acid, decreased serum potassium, elevated gamma-glutamyl transferase, elevated alanine aminotransferase, elevated aspartate aminotransferase, elevated liver enzymes, elevated serum creatine kinase, weight loss, weight gain, rhabdomyolysis, chronic malabsorption syndrome, intestinal vascular edema, altered consciousness, drug hypersensitivity, epigastric pain, decreased libido, genital edema, asthenia, eczema, limb pain, mild decrease in average hemoglobin and hematocrit levels, dizziness, benign prostatic hyperplasia, benign salivary gland neoplasm, cerebral infarction, renal failure, abdominal bloating, facial flushing, nosebleeds, prostatic hyperplasia, prostatitis, dysphagia, papular rash, renal cell dysplasia, acute deafness, lymphadenitis, acute respiratory distress syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It should be kept at room temperature between 1 to 30 degrees Celsius to maintain its efficacy for a longer duration.

Appearance and packaging

Appearance

White and orange round film-coated tablets

Package unit

30 tablets (10 tablets/Alu-Alu × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.